Trademark Application for “MEMORIAL HERMANN HEALTH PLAN MEDICARE ADVANTAGE PLANS HEALTH PLAN COMMERCIAL GROUPS” Filed by Memorial Hermann Health System: Memorial Hermann Health System
Health Policy and Law Daily
2026 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Health Policy and Law Daily -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “MEMORIAL HERMANN HEALTH PLAN MEDICARE ADVANTAGE PLANS HEALTH PLAN COMMERCIAL GROUPS” by William H. Dietrich Conley Rose, P.C., representing Memorial Hermann Health System. This application was made available to the public on July 06, 2026.
The international trademark goods and services class codes for this trademark application are 035 and 036.
The serial number for this application is 99170274.
The applicant indicates that “The mark consists of the phrase ‘MEMORIAL HERMANN’ with a glowing ‘O’ in Memorial separated by a vertical line from the phrases ‘Health Plan,’ ‘Medicare Advantage Plans,’ and ‘Health Plan Commercial Groups’.”
As submitted by the applicant, this trademark application relates to the following goods and services:
• Business administration of wellness, therapy and health plans for others, namely, employers;
• Insurance services, namely, insurance consulting and underwriting in the field of individual and group health insurance plans.
The registrar information for this application is: William H. Dietrich Conley Rose, P.C., 4965 Preston Park Blvd, Suite 195, Plano, TX 75093, United States.�� Keywords for this news article include: Health Policy, Health and Medicine, Managed Care, Medicare, Medicare and Medicaid, Memorial Hermann Health System.
(Our reports deliver fact-based news of research and discoveries from around the world.)
Studies from Yangtze University Yield New Information about Investment (Robust Optimal Reinsurance and Investment With Inflation Risk: a Game-theoretic Approach and Explicit Solutions): Investment
New Life Science Study Findings Recently Were Reported by Researchers at Johns Hopkins University Bloomberg School of Public Health (Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United States): Life Science
Advisor News
- Flourish brings private-bank-like cash solution to MassMutual’s network
- Majority of Americans concerned recent market highs are unsustainable
- GLP-1 users choose between medication and retirement saving
- Gen X and millennials seek new retirement model
- Are families ready for the costs of aging at home?
More Advisor NewsAnnuity News
- New class-action lawsuit targets Delaware Life over annuity disclosures
- A client remarried: Does their annuity still fit?
- Gen X and millennials seek new retirement model
- Global Atlantic names Dan Farrelly head of IMO and IBD channels
- A rising retirement challenge: The license to spend
More Annuity NewsHealth/Employee Benefits News
Life Insurance News